AACA_MAMSC
ID AACA_MAMSC Reviewed; 479 AA.
AC Q7ATH9;
DT 21-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT 05-JUL-2004, sequence version 1.
DT 03-AUG-2022, entry version 79.
DE RecName: Full=Bifunctional AAC/APH;
DE Includes:
DE RecName: Full=6'-aminoglycoside N-acetyltransferase;
DE EC=2.3.1.-;
DE AltName: Full=AAC(6');
DE Includes:
DE RecName: Full=Aminoglycoside 2''-phosphotransferase;
DE AltName: Full=2''-aminoglycoside phosphotransferase;
DE EC=2.7.1.190 {ECO:0000250|UniProtKB:P0A0C2};
DE AltName: Full=APH(2'');
GN Name=aacA-aphD;
OS Mammaliicoccus sciuri (Staphylococcus sciuri).
OG Plasmid pGTK2.
OC Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC Mammaliicoccus.
OX NCBI_TaxID=1296;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX PubMed=12716781; DOI=10.1093/jac/dkg257;
RA Lange C.C., Werckenthin C., Schwarz S.;
RT "Molecular analysis of the plasmid-borne aacA/aphD resistance gene region
RT of coagulase-negative staphylococci from chickens.";
RL J. Antimicrob. Chemother. 51:1397-1401(2003).
CC -!- FUNCTION: Involved in resistance to gentamicin, tobramycin, and
CC kanamycin. Tobramycin and kanamycin resistance is due to the ACC
CC activity, specified by N-terminal region. The C-terminal region is a
CC kinase that phosphorylates several 4,6-disubstituted aminoglycosides.
CC {ECO:0000250|UniProtKB:P0A0C2}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=a gentamycin + GTP = a gentamycin 2''-phosphate + GDP + H(+);
CC Xref=Rhea:RHEA:48872, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565,
CC ChEBI:CHEBI:58189, ChEBI:CHEBI:90218, ChEBI:CHEBI:90219;
CC EC=2.7.1.190; Evidence={ECO:0000250|UniProtKB:P0A0C2};
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC -!- SIMILARITY: In the C-terminal section; belongs to the aminoglycoside
CC phosphotransferase family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AJ536193; CAD60203.1; -; Genomic_DNA.
DR RefSeq; WP_001028144.1; NZ_KX982171.1.
DR AlphaFoldDB; Q7ATH9; -.
DR SMR; Q7ATH9; -.
DR STRING; 1232666.JANE01000006_gene1918; -.
DR GeneID; 58049990; -.
DR GeneID; 61913521; -.
DR GeneID; 66882989; -.
DR eggNOG; COG1670; Bacteria.
DR eggNOG; COG3173; Bacteria.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0034071; F:aminoglycoside phosphotransferase activity; IEA:UniProtKB-EC.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR GO; GO:0008080; F:N-acetyltransferase activity; IEA:InterPro.
DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW.
DR GO; GO:0046677; P:response to antibiotic; IEA:UniProtKB-KW.
DR InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR InterPro; IPR002575; Aminoglycoside_PTrfase.
DR InterPro; IPR000182; GNAT_dom.
DR InterPro; IPR011009; Kinase-like_dom_sf.
DR Pfam; PF01636; APH; 1.
DR SUPFAM; SSF55729; SSF55729; 1.
DR SUPFAM; SSF56112; SSF56112; 1.
DR PROSITE; PS51186; GNAT; 1.
PE 3: Inferred from homology;
KW Acyltransferase; Antibiotic resistance; ATP-binding; Cytoplasm; Kinase;
KW Multifunctional enzyme; Nucleotide-binding; Plasmid; Transferase.
FT CHAIN 1..479
FT /note="Bifunctional AAC/APH"
FT /id="PRO_0000223384"
FT DOMAIN 8..180
FT /note="N-acetyltransferase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00532"
FT REGION 110..153
FT /note="Acetyl-CoA binding site"
FT /evidence="ECO:0000250"
FT ACT_SITE 374
FT /note="Proton acceptor; for phosphotransferase activity"
FT /evidence="ECO:0000250"
FT BINDING 393
FT /ligand="a gentamycin"
FT /ligand_id="ChEBI:CHEBI:90218"
FT /evidence="ECO:0000250"
SQ SEQUENCE 479 AA; 56855 MW; 744D93D76299CFCE CRC64;
MNIVENEICI RTLIDDDFPL MLKWLTDERV LEFYGGRDKK YTLESLKKHY TEPWEDEVFR
VIIEYNNVPI GYGQIYKMYD ELYTDYHYPK TDEIVYGMDQ FIGEPNYWSK GIGTRYIKLI
FEFLKKERNA NAVILDPHKN NPRAIRAYQK SGFRIIEDLP EHELHEGKKE DCYLMEYRYD
DNATNVKAMK YLIEHYFDNF KVDSIEIIGS GYDSVAYLVN NEYIFKTKFS TNKKKGYAKE
KAIYNFLNTN LETNVKIPNI EYSYISDELS ILGYKEIKGT FLTPEIYSTM SEEEQNLLKR
DIASFLRQMH GLDYTDISEC TIDNKQNVLE EYILLRETIY NDLTDIEKDY IESFMERLNA
TTVFEGKKCL CHNDFSCNHL LLDGNNRLTG IIDFGDSGII DEYCDFIYLL EDSEEEIGTN
FGEDILRMYG NIDIEKAKEY QDIVEEYYPI ETIVYGIKNI KQEFIENGRK EIYKRTYKD